This profile of a sustained, elevated IL-18 level associated with poor clinical outcomes is in keeping with our findings that persistently elevated fIL-18 levels from symptom day 15 onwards are significantly associated with disease severity and 60-day mortality, in COVID-19. Here, IL18 is linked to COVID-19.